Literature DB >> 20664075

Gut microbiota in health and disease.

Inna Sekirov1, Shannon L Russell, L Caetano M Antunes, B Brett Finlay.   

Abstract

Gut microbiota is an assortment of microorganisms inhabiting the length and width of the mammalian gastrointestinal tract. The composition of this microbial community is host specific, evolving throughout an individual's lifetime and susceptible to both exogenous and endogenous modifications. Recent renewed interest in the structure and function of this "organ" has illuminated its central position in health and disease. The microbiota is intimately involved in numerous aspects of normal host physiology, from nutritional status to behavior and stress response. Additionally, they can be a central or a contributing cause of many diseases, affecting both near and far organ systems. The overall balance in the composition of the gut microbial community, as well as the presence or absence of key species capable of effecting specific responses, is important in ensuring homeostasis or lack thereof at the intestinal mucosa and beyond. The mechanisms through which microbiota exerts its beneficial or detrimental influences remain largely undefined, but include elaboration of signaling molecules and recognition of bacterial epitopes by both intestinal epithelial and mucosal immune cells. The advances in modeling and analysis of gut microbiota will further our knowledge of their role in health and disease, allowing customization of existing and future therapeutic and prophylactic modalities.

Entities:  

Mesh:

Year:  2010        PMID: 20664075     DOI: 10.1152/physrev.00045.2009

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  1168 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

Review 2.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

Review 4.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

Review 5.  The potter's wheel: the host's role in sculpting its microbiota.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

6.  Shifting from a gene-centric to metabolite-centric strategy to determine the core gut microbiome.

Authors:  Julian R Marchesi
Journal:  Bioeng Bugs       Date:  2011-11-01

7.  Does the human gut microbiota contribute to the etiology of autism spectrum disorders?

Authors:  Petra Louis
Journal:  Dig Dis Sci       Date:  2012-08       Impact factor: 3.199

8.  Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants.

Authors:  Anders Bergström; Thomas Hjort Skov; Martin Iain Bahl; Henrik Munch Roager; Line Brinch Christensen; Katrine Tschentscher Ejlerskov; Christian Mølgaard; Kim F Michaelsen; Tine Rask Licht
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

9.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

10.  Salivary Microbiota Associated with Immunoglobulin A Nephropathy.

Authors:  Maria Piccolo; Maria De Angelis; Gabriella Lauriero; Eustacchio Montemurno; Raffaella Di Cagno; Loreto Gesualdo; Marco Gobbetti
Journal:  Microb Ecol       Date:  2015-03-13       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.